IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Eris Lifesciences IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 1741.16 Cr. The company is based in Ahmedabad and caters to Pharmaceutical sector. Axis Capital , Citigroup Global Markets India , Credit Suisse Securities (India) are the merchant bankers of Eris Lifesciences IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 8th February 2017.
Eris Lifesciences IPO open date is 16th June 2017 and close date is 20th June 2017. IPO Allotment Date is 23rd June 2017 and Listing date is 29th June 2017.
IPO
Size:
₹ 1741.16 Cr.
Avg IPO Size (Sector Based)
: ₹
1,431.30 cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
Axis Capital
IPO by BRLM so far:
163
City:
Ahmedabad
IPO so far:
32
Revenue (annualised):
₹
744.07
cr. 
PE
Ratio:
34.00x
Average Sector PE Ratio: 27.10x
Eris Lifesciences IPO size is ₹ 1741.16 Cr. with IPO price of ₹ 603.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Axis Capital Limited is the book-running lead manager of the Eris Lifesciences IPO. Link Intime India Private Limited is the Registrar for Eris Lifesciences IPO.
Eris Lifesciences IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Eris Lifesciences IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on developer manufacturer and commercializer of branded pharmaceutical produ. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Eris Lifesciences IPO size is ₹ 1741.16 Cr. with fresh issue size of ₹ 1,741 and Offer for sale being ₹ Nil
The IPO allotment date for Eris Lifesciences IPO is expected to be 23rd June 2017, after the finalization of basis of allotment. Investors can check Eris Lifesciences IPO allotment status on the registrars website, Link Intime India Private Limited . Eris Lifesciences IPO refund dates are 27th June 2017.
Eris Lifesciences IPO is expected to be listed on 29th June 2017.
The upper price band for the Eris Lifesciences IPO is set at ₹ 603.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Eris Lifesciences IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Eris Lifesciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 20th June 2017. After submission, funds are blocked until the basis of allotment of Eris Lifesciences IPO is finalised.
The merchant banker for Eris Lifesciences IPO is Axis Capital Limited , Citigroup Global Markets India Private Limited , Credit Suisse Securities (India) Private Limited . Axis Capital Limited , Citigroup Global Markets India Private Limited , Credit Suisse Securities (India) Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Eris Lifesciences IPO RHP for further details.
The registrar for Eris Lifesciences IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Eris Lifesciences IPO through their official website or helpline.
Eris Lifesciences IPO was subscribed 3.29 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 1,741.16 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,431.30 Cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
Axis Capital
IPO by BRLM so far:
163
City:
Ahmedabad
IPO so far:
32
Revenue (annualised):
₹ 724.96 cr.
PE
Ratio:
34.00x
Average Sector PE Ratio: 27.10x
Eris Lifesciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Eris Lifesciences Financial Review Page
Merchant Banker(s) of Eris Lifesciences IPO: Axis Capital Limited , Citigroup Global Markets India Private Limited , Credit Suisse Securities (India) Private Limited
Eris Lifesciences IPO subscription was 3.29 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Eris Lifesciences IPO listed at a listing price of 601.05 against the offer price of 603.00.
The current market price of Eris Lifesciences is 1762.80.
Why Us?
